A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.
Market Scope
Trusted Partner of Industry and Medical Professionals for Market Data, Independent Perspective, & Objective Analysis
Latest Reports Latest News
Market Scope Methodology
A Multi-Step Approach for Accurate & Timely Data
Proprietary data
- 20+ years of physician survey data
- Disease models
- Cultivated database of physicians, ASCs, and hospitals
- Insight from our team of in-house industry experts
Public data
- Attendance and participation at major, worldwide meetings
- Public health systems and registries
- Clinical study data
- Analysis of company-published financial reports
Physician Surveys
For 20+ years, we have surveyed physicians to provide both physicians & industry professionals unbiased insight into the market.
Complete a Survey
On average, our surveys take only 5 to 15 minutes to complete. Survey results help you analyze practice patterns, evaluate treatment choices, and benchmark your practice.
Benchmark Your Performance
Benchmark reports allow you to gauge your performance, track your practice metrics over time, and compare your practice to national averages.
View Market Insights & Analytics
Additional free data tools include instant survey results, weekly polls, PowerPoint charts, and more.
Learn More Register Today
Latest Market Reports
Market Scope's industry reports are meticulously prepared by a dedicated team of in-house consultants/analysts with over 100 years of collective experience.
- 13
Comprehensive Pages
- 34
States Represented
- 106
Survey Participants
- 18
COVID-19 Impact Topics Covered
Latest Industry News & Trends
10/23/2020
BreakingMergersOphthalmicPharmaRetina
China’s AffaMed, EverInsight to Merge
China’s AffaMed Therapeutics announced Oct. 14 that it was merging with EverInsight Therapeutics, also of China. The combined entity, which will retain the AffaMed name, will focus on development o...
10/23/2020
BreakingGene TherapyMergersOphthalmicRetina
Gemini Gains Nasdaq Listing in $216 Million Merger Deal with FS Development
Cambridge, Massachusetts-based Gemini Therapeutics will merge with FS Development Corp. to create a Nasdaq-listed company focused on age-related macular degeneration, the companies reported Oct. 15...
10/23/2020
AcquisitionsBreakingOphthalmicSurgical
Katena Acquires Micro-Select Instruments
Katena Products of Parsippany, New Jersey, announced Oct. 20 that it had acquired Micro-Select Instruments of St. Clair, Missouri. Micro-Select, founded in 2005, specializes in manufacturing high-p...
10/23/2020
BreakingDealsOphthalmicPharmaRefractive
Zhaoke Licenses Nevakar’s Myopia Candidate in Asian Markets
Nevakar, of Bridgewater, New Jersey, announced Oct. 20 that Hong Kong’s Zhaoke Ophthalmology had licensed Nevakar’s NVK-002 for pediatric myopia in the Greater China market, South Korea, and Southe...
10/23/2020
BreakingDry EyeOphthalmicPharmaRegulation
Medicom’s Evolve Intensive Gel for Dry Eye Wins Approval in Canada
Medicom Healthcare, of the UK, and its partner Aequus Pharmaceuticals, of Canada, announced Oct. 19 that Aequus had secured approval in Canada for Evolve Intensive Gel—a crosslinked combination of ...
10/23/2020
BreakingCataractClinical TrialOphthalmicSurgical
Positive Phase III Results for Sun Pharma Drop for Post-op Inflammation, Pain
Indian company Sun Pharma announced Oct. 14 that it saw positive topline results from its Phase III trial of SDN-037 for the treatment of inflammation and pain associated with ocular surgery. The p...
10/23/2020
BreakingFundingGene TherapyOphthalmicRetina
French Gene Therapy Company SparingVision Raises $52.8 Million, Appoints New CEO
French gene therapy company SparingVision announced Oct. 21 that it had raised €44.5 million (US $52.8 million) in its latest financing round. The round was led by 4BIO Capital and UPMC Enterprises...
10/23/2020
BreakingDry EyeFundingOphthalmic
Azura Raises $20 Million to Advance its Candidate for MGD
Azura Ophthalmics announced Oct. 22 that it had completed a $20 million financing round, led by existing investors including OrbiMed, TPG Biotech, Brandon Capital’s Medical Research Commercializati...
Join Market Scope Today
Register A Corporate Account
Register A Clinical Account
A clinical account gives you access to survey participation and results, weekly polls, benchmark reports, a searchable news archive, and more on a personalized dashboard.